Determining the off-target activity of antibiotics and novel translation initiation sites in mitochondria

Reviewer #1 (Public review):

Summary:

This study aimed to determine whether bacterial translation inhibitors affect mitochondria through the same mechanisms. Using mitoribosome profiling, the authors found that most antibiotics, except telithromycin, act similarly in both systems. These insights could help in the development of antibiotics with reduced mitochondrial toxicity.

They also identified potential novel mitochondrial translation events, proposing new initiation sites for MT-ND1 and MT-ND5. These insights not only challenge existing annotations but also open new avenues for research on mitochondrial function.

Strengths:

Ribosome profiling is a state-of-the-art method for monitoring the translatome at very high resolution. Using mitoribosome profiling, the authors convincingly demonstrate that most of the analyzed antibiotics act in the same way on both bacterial and mitochondrial ribosomes, except for telithromycin. Additionally, the authors report possible alternative translation events, raising new questions about the mechanisms behind mitochondrial initiation and start codon recognition in mammals.

Weaknesses:

All the weaknesses I previously highlighted were adequately addressed.

Reviewer #3 (Public review):

Summary:

Recently, the off-target activity of antibiotics on human mitoribosome has been paid more attention in the mitochondrial field. Hafner et al applied mitoribosome profiling to study the effect of antibiotics on protein translation in mitochondria as there are similarities between bacterial ribosome and mitoribosome. The authors conclude that some antibiotics act on mitochondrial translation initiation by the same mechanism as in bacteria. On the other hand, the authors showed that chloramphenicol, linezolid and telithromycin trap mitochondrial translation in a context-dependent manner. More interesting, during deep analysis of 5' end of ORF, the authors reported the alternative start codon for ND1 and ND5 proteins instead of previously known one. This is a novel finding in the field and it also provide another application of the technique to further study on mitochondrial translation.

Strengths:

This is the first study which applied mitoribosome profiling method to analyze multiple antibiotics treatment cells. The mitoribosome profiling method had been optimized carefully and has been suggested to be a novel method to study translation events in mitochondria. The manuscript is constructive and well-written.

Comments on revisions:

The authors added a discussion to the revised manuscript, and also carefully investigate structural data from others. I have no more comment. Congratulations to the team for a good manuscript!

Author response:

The following is the authors’ response to the previous reviews

Reviewer #1 (Public review):

Summary:

This study aimed to determine whether bacterial translation inhibitors affect mitochondria through the same mechanisms. Using mitoribosome profiling, the authors found that most antibiotics, except telithromycin, act similarly in both systems. These insights could help in the development of antibiotics with reduced mitochondrial toxicity.

They also identified potential novel mitochondrial translation events, proposing new initiation sites for MT-ND1 and MT-ND5. These insights not only challenge existing annotations but also open new avenues for research on mitochondrial function.

Strengths:

Ribosome profiling is a state-of-the-art method for monitoring the translatome at very high resolution. Using mitoribosome profiling, the authors convincingly demonstrate that most of the analyzed antibiotics act in the same way on both bacterial and mitochondrial ribosomes, except for telithromycin. Additionally, the authors report possible alternative translation events, raising new questions about the mechanisms behind mitochondrial initiation and start codon recognition in mammals.

Weaknesses:

All the weaknesses I previously highlighted were adequately addressed.

We thank the reviewer for carefully considering our revision.

Reviewer #3 (Public review):

Summary:

Recently, the off-target activity of antibiotics on human mitoribosome has been paid more attention in the mitochondrial field. Hafner et al applied mitoribosome profilling to study the effect of antibiotics on protein translation in mitochondria as there are similarities between bacterial ribosome and mitoribosome. The authors conclude that some antibiotics act on mitochondrial translation initiation by the same mechanism as in bacteria. On the other hand, the authors showed that chloramphenicol, linezolid and telithromycin trap mitochondrial translation in a context-dependent manner. More interesting, during deep analysis of 5' end of ORF, the authors reported the alternative start codon for ND1 and ND5 proteins instead of previously known one. This is a novel finding in the field and it also provide another application of the technique to further study on mitochondrial translation.

Strengths:

This is the first study which applied mitoribosome profiling method to analyze mutiple antibiotics treatment cells. The mitoribosome profiling method had been optimized carefully and has been suggested to be a novel method to study translation events in mitochondria. The manuscript is constructive and well-written.

Weaknesses:

This is a novel and interesting study, however, most of conclusion comes from mitoribosome profiling analysis, as the result, the manuscript lacks the cellular biochemical data to provide more evidence and support the findings.

Comments on revisions:

The authors addressed most of my concerns and comments, although there is still no biochemical assay which should be performed to support mitoribsome profiling data.

The author also carefully investigated the structure of complex I, however, I am surprised that the author chose to analyse a low-resolution structure (3.7 A). Recently, there are more high-resolution structures of mammalian complex I published (7R41, 7V2C, 7QSM, 9I4I). Furthermore, the authors should not only respond to the reviewers but also (somehow) discuss these points in the manuscript.

We thank the reviewer for suggesting additional structural analyses. Of the suggested additional structures to look at, only 9I4I from Nguyen et al. 2026 was of human-derived complex I. Other structures were derived from species that utilized alternative codons at the 3’ end of these mRNAs, preventing comparison. However, for 9I4I, the authors were able to fit density for every amino acid of all mitochondrially-encoded proteins in complex I, except the first two residues of ND1 and ND5, which, as our manuscript suggest, are not translated.

In addition to structures, we also attempted to identify additional publicly available mass spectrometry data for complex I. However, data which we identified either derived their proteins from bovine tissue, which utilizes different codons at the initiation sites, or did not capture the N-terminal region of the proteins. Therefore, we did not include this analysis.